Literature DB >> 30798140

Bu-Shen-Yi-Qi formula ameliorates airway remodeling in murine chronic asthma by modulating airway inflammation and oxidative stress in the lung.

Jie Cui1, Fei Xu2, Zhao Tang2, Wenqian Wang2, Ling Li Hu2, Chen Yan2, Qingli Luo2, Hongjian Gao3, Ying Wei4, Jingcheng Dong5.   

Abstract

Bu-Shen-Yi-Qi formula (BSYQF) could suppress chronic airway inflammation according to previous studies. However, there is relatively little direct experimental evidence to evaluate the effects of BSYQF treatment on airway remodeling in chronic asthma. Recent evidence suggests that oxidative stress is involved in airway inflammation and airway remodeling in chronic asthma. BSYQF which includes various of chemical components having antioxidant effects, could be beneficial in attenuating airway remodeling in chronic asthma. The purpose of this study was to elucidate the effect of BSYQF treatment on airway remodeling and investigate its potential mechanisms in chronic asthma. To develop the murine models of chronic asthma, BALB/c mice were sensitized and challenged to ovalbumin for 8 weeks. BSYQF (5, 10, 20 g raw herbs/kg body weight) or tiotropium bromide (0.1 mM) were administered orally and intranasal instillation, respectively. The effect of BSYQF on pulmonary inflammation and remodeling was evaluated. The parameters of oxidative stress in the lung were analyzed. BSYQF treatment reduced airway hyperresponsiveness (AHR), Th2 response including IL-4, IL-13, and OVA-specific IgE and IgG1, transforming growth factor-β (TGF-β), vascular endothelium growth factor (VEGF), airway inflammation and airway remodeling including smooth muscle thickening and peribronchial collagen deposition. As for oxidative stress, BSYQF treatment reduced reactive oxygen species (ROS), Malondialdehyde (MDA), NO, and the expression of inducible nitric oxide synthase (iNOS), but increased significantly glutathione (GSH) /Oxidized glutathione(GSSH) ratios in the lung, restored mitochondrial ultrastructural changes of bronchial epithelia and ATP levels in the lung. In summary, this study suggested that BSYQF treatment ameliorated airway remodeling and alleviated asthmatic features in chronic asthma models. Anti-inflammatory and antioxidant effect of BSYQF may explain why BSYQF has effects on preventing airway remodeling.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Airway inflammation; Airway remodeling; Bu-Shen-Yi-Qi formulae (BSYQF); Chronic asthma; Oxidative stress

Mesh:

Substances:

Year:  2019        PMID: 30798140     DOI: 10.1016/j.biopha.2019.108694

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  8 in total

1.  Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology.

Authors:  Yuanyuan Zhong; Lingli Hu; Wenjing Chen; Bin Wang; Jing Sun; Jingcheng Dong
Journal:  BMC Complement Med Ther       Date:  2022-06-07

Review 2.  Concepts of advanced therapeutic delivery systems for the management of remodeling and inflammation in airway diseases.

Authors:  Daljeet Singh Dhanjal; Parvarish Sharma; Meenu Mehta; Murtaza M Tambuwala; Parteek Prasher; Keshav R Paudel; Gang Liu; Shakti D Shukla; Philip M Hansbro; Dinesh Kumar Chellappan; Kamal Dua; Saurabh Satija
Journal:  Future Med Chem       Date:  2022-01-12       Impact factor: 3.808

3.  Efficacy and safety of modified Bushen Yiqi formulas (MBYF) as an add-on to formoterol and budesonide in the management of COPD: study protocol for a multicentre, double-blind, placebo-controlled, parallel-group, randomized clinical trial: FB-MBYF Trial.

Authors:  Qing Kong; Yuxue Cao; Zhen Gao; Jing Sun; Hongying Zhang; Yijie Du; Yubao Lv; Sihan Zhou; Zihui Tang; Baojun Liu; Jingcheng Dong
Journal:  Trials       Date:  2022-02-14       Impact factor: 2.279

4.  Acupoint Catgut-Embedding Therapy Inhibits NF-κB/COX-2 Pathway in an Ovalbumin-Induced Mouse Model of Allergic Asthma.

Authors:  Fangzhou Teng; Xuedong Ma; Jie Cui; Xueyi Zhu; Weifeng Tang; Wenqian Wang; Tulake Wuniqiemu; Jingjing Qin; Yuting Zong; Chengyong Liu; Shiyuan Wang
Journal:  Biomed Res Int       Date:  2022-03-02       Impact factor: 3.411

Review 5.  The Role and Mechanisms of Traditional Chinese Medicine for Airway Inflammation and Remodeling in Asthma: Overview and Progress.

Authors:  Bo-Wen Zhou; Hua-Man Liu; Xin-Hua Jia
Journal:  Front Pharmacol       Date:  2022-07-15       Impact factor: 5.988

6.  Jia-Wei-Yu-Ping-Feng-San Attenuates Group 2 Innate Lymphoid Cell-Mediated Airway Inflammation in Allergic Asthma.

Authors:  Lingna Xue; Cui Li; Guangbo Ge; Shaoyan Zhang; Liming Tian; Yu Wang; Huiyong Zhang; Zifeng Ma; Zhenhui Lu
Journal:  Front Pharmacol       Date:  2021-07-09       Impact factor: 5.810

7.  Tetrandrine Ameliorates Airway Remodeling of Chronic Asthma by Interfering TGF-β1/Nrf-2/HO-1 Signaling Pathway-Mediated Oxidative Stress.

Authors:  Yiping Lin; Jingchan Yao; Meiling Wu; Xiaoqian Ying; Mingxing Ding; Yanli Wei; Xiaoyan Fu; Wei Feng; Yunguang Wang
Journal:  Can Respir J       Date:  2019-11-03       Impact factor: 2.409

8.  Correlation between sestrin2 expression and airway remodeling in COPD.

Authors:  Da-Wei Zhang; Yuan-Yuan Wei; Shuang Ji; Guang-He Fei
Journal:  BMC Pulm Med       Date:  2020-11-16       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.